<i>In Vivo</i> Expression of Reprogramming Factor OCT4 Ameliorates Myelination Deficits and Induces Striatal Neuroprotection in Huntington’s Disease
White matter atrophy has been shown to precede the massive loss of striatal GABAergic neurons in Huntington’s disease (HD). This study investigated the effects of <i>in vivo</i> expression of reprogramming factor octamer-binding transcription factor 4 (OCT4) on neural stem cell (NSC) nic...
Main Authors: | Ji-Hea Yu, Bae-Geun Nam, Min-Gi Kim, Soonil Pyo, Jung-Hwa Seo, Sung-Rae Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/5/712 |
Similar Items
-
Manipulation of microbiota reveals altered callosal myelination and white matter plasticity in a model of Huntington disease
by: Carola I. Radulescu, et al.
Published: (2019-07-01) -
Cell Reprogramming to Model Huntington’s Disease: A Comprehensive Review
by: Ruth Monk, et al.
Published: (2021-06-01) -
Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity
by: Ryoma Morigaki, et al.
Published: (2017-06-01) -
Oligodendroglial Energy Metabolism and (re)Myelination
by: Vanja Tepavčević
Published: (2021-03-01) -
Mutant HTT does not affect glial development but impairs myelination in the early disease stage
by: Sitong Yang, et al.
Published: (2023-07-01)